Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Remdesivir bulk supplier for pharma manufacturers

Remdesivir Suppliers & Bulk Manufacturers

Available Forms: Lyophilized powder for IV & Injection

Available Strengths: Powder(100 mg/vial); Injection: 100 mg/20 mL (5 mg/mL)

Reference Brands: Veklury® (EU & US)

Category: Anti Covid Medicines

Remdesivir is an antiviral for COVID-19, sold by Gilead as Veklury and given by intravenous infusion, usually from a 100 mg lyophilised powder vial. Several Indian companies have made generic remdesivir under voluntary licences from Gilead that cover a defined list of countries. We confirm the manufacturer, the licence position for your market, documents and lead time for each order.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Remdesivir? List it or send an offer →

Product Description:

Remdesivir is a nucleotide-analogue antiviral that blocks the RNA polymerase of SARS-CoV-2, the virus that causes COVID-19. Gilead's Veklury is approved in the US for COVID-19 in hospitalised patients and in the EU for COVID-19 pneumonia needing supplemental oxygen. Both also approve a three-day course for high-risk patients with milder disease (in the US, patients not in hospital; in the EU, patients not needing oxygen). It is given by intravenous infusion, most often from a 100 mg vial of lyophilised powder that is reconstituted and then diluted.

Remdesivir manufacturing in India

In 2020 Gilead signed voluntary, non-exclusive licences with a group of generic manufacturers, most of them based in India, allowing them to make remdesivir and sell it in 127 countries, mostly low- and middle-income. Several Indian manufacturers took up these licences, and their products were used widely in India during the 2021 wave.

Demand is far lower than at the pandemic peak, so availability, batch size and lead time vary by manufacturer and are best confirmed at the time of enquiry. Before you buy, check:

  • Licence territory. Generic remdesivir made under the Gilead licences may be sold only in the countries the licences cover. For any other market, the patent and registration position has to be checked before an order.
  • Registration. Most markets require the specific product to be registered or authorised, or imported through a tender, emergency-use or named-patient route.
  • Storage and shelf life. Under the US label the lyophilised powder is stored below 30 °C; an earlier solution concentrate needed refrigeration at 2 to 8 °C. Follow the labelling of the product offered and check its remaining shelf life.

Remdesivir API

Some of the licensees have made remdesivir API in India for their own finished products. Supply of the API to third parties depends on the same licence terms, so tell us the intended finished product and market when you enquire.

We work with hospitals, distributors and tender suppliers; see our government tender supply service, or send us an RFQ with the quantity and destination market. Related products include molnupiravir and baricitinib.

Remdesivir — third party manufacturing & bulk supply

Remdesivir is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Remdesivir is supplied as Lyophilized powder for IV & Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Remdesivir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Remdesivir →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Several Indian manufacturers make remdesivir under Gilead's 2020 licences, though not all of them still produce it regularly. We match your enquiry with licensed makers that can supply your market and confirm current availability and documents.

No. The Gilead licences allow sale in a defined list of 127 countries, mostly low- and middle-income. For a market outside that list, patent and registration status must be checked first.

100 mg per vial, mainly as a lyophilised powder for reconstitution and dilution. A 100 mg/20 mL (5 mg/mL) solution was also approved in the US but is no longer in the current US label.

Under the US label, the lyophilised powder is stored below 30 °C; the older solution concentrate needed 2 to 8 °C. Storage statements differ between countries and products, so follow the labelling of the product you buy.

Related Products

Favipiravir Tablet

Strength:
200 mg, 400 mg, 600 mg

Form: Tablet

Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)

View Details
Molnupiravir

Strength:
200 mg

Form: Oral capsule

Reference Brands: Lagevrio®(Us & EU)

View Details
Tocilizumab

Strength:
IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)

Form: IV injection, SQ Injection

Reference Brands: Actemra®(US); RoActemra®(EU)

View Details
Nirmatrelvir / Ritonavir Tablet

Strength:
Nirmatrelvir(150 mg) + Ritonavir(100 mg)

Form: Tablet

Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)

View Details
Baricitinib

Strength:
2 mg, 4 mg

Form: Tablet

Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us